Overview

Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease

Status:
Recruiting
Trial end date:
2027-03-02
Target enrollment:
Participant gender:
Summary
This study evaluate the efficacy and safety of benznidazole in the treatment of chronic indeterminate Chagas disease in children. All subjects will receive benznidazole and results will be compared to historically to a placebo arm.
Phase:
Phase 3
Details
Lead Sponsor:
Insud Pharma
Collaborator:
Chemo Research S.L.
Treatments:
Benzonidazole